SUKA Becomes Key Player in Cellular Anti-Aging Through Full Buyout of Australian Pharma Leader Sylum

Shenzhen, China – October 29, 2024 —

Chinese brand SUKA has announced the full acquisition of Australian brand Sylum, marking a major step forward in SUKA’s brand-upgrading strategy. This acquisition deepens SUKA’s presence in the cellular anti-aging industry, with a focus on providing the market with high-tech, premium anti-aging products and services.

Comprehensive permeation of cellular anti-aging industry chain

Following the acquisition of Sylum, SUKA plans to support the company in advancing high-tech research and development, streamlining supply chain management, and bringing relevant research findings to market. With Sylum as a springboard, SUKA aims to quickly expand into Australian and global markets, leveraging its expertise in nutrition, cytology, and other research areas, along with its strengths in lean management and corporate operations.

Founded in Victoria, Australia, in 2018, Sylum operates under F7 and ISO 8 cleanroom standards, focusing on the research and production of high-quality functional products for health. With a team of renowned experts in food science and nutrition, the company has developed over 100 products across diverse categories, including infant nutrition, specialized medical nutrition, male health, female wellness, and sports nutrition.

Partnership drives exploration of cutting-edge applications in cellular anti-aging

Another major step by SUKA in the cellular anti-aging sector is its strategic partnership with the scientific team at Digestive Health Institute (DHI) in New Zealand. This team has long focused on developing functional food ingredients and products targeting metabolic syndrome, hormonal balance in men and women, immune system rejuvenation, cardiovascular health, diabetes prevention, and cancer inhibition. They also hold a series of innovative technologies and related patents.

A SUKA executive commented on the collaboration, stating that SUKA and the DHI scientific team will work together to optimize the allocation and utilization of technology, raw materials, talent, and other resources. Their goal is to build a robust innovation ecosystem that enhances the efficiency of converting scientific research into practical applications, ultimately shaping a new blueprint for advancements in cellular anti-aging.

Debut of New Product: Regetting-18 Revitalizing Drink

The global anti-aging market has been growing steadily, reaching $216 billion in 2021. With the rise of a new generation of consumers, China’s anti-aging market is also expanding rapidly and is projected to reach a potential of $100 billion (Forbes data). Many Chinese health brands now see the anti-aging market as a promising growth area. SUKA, a leading brand in this sector, has launched its new Regetting-18 Revitalizing Drink, positioning itself at the forefront of industry innovation.

The new Regetting-18 Revitalizing Drink is based on third-generation, medical-grade anti-aging technology and incorporates three key components: NO precursor, polyphenol alcohol, and polysaccharide nutrients. It offers two primary functions –targeted activation of microcirculation and nutrient reperfusion for cellular protection. Users experience three notable sensations: a 3-5x boost in microcirculation, a tingling sensation, and a mild skin flush. The drink supports cellular revitalization, cellular microcirculation enhancement, and improved mitochondrial function.

From its full acquisition of Sylum to its collaboration with New Zealand’s DHI scientific team and the launch of the new Regetting-18 Revitalizing Drink, SUKA is committed to building a comprehensive ecosystem for cellular anti-aging research, development, and market operations. SUKA’s mission is to safeguard the health and wellness of customers worldwide.

Contact Info:
Name: Zheng Bingbing
Email: Send Email
Organization: Shenzhen Suka Health Industry Co., Ltd
Website: http://sylum.cn/

Release ID: 89144738

Should you come across any errors, concerns, or inconsistencies within this press release’s content, we urge you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.